Table 1 Patient characteristics
|  | ECHO (n = 15) | EGDT (n = 15) | p value |
|---|---|---|---|
Age (median, IQR) | 69 (61,77) | 64(49,75) | 0.41 |
Female (n, %) | 7 (53) | 8 (47) | > 0.99 |
Infection site (n, %) | > 0.99 | ||
 Abdominal | 1 (6.7) | 2 (13.3) | |
 Pulmonary | 6 (40) | 6 (40) | |
 Skin and soft tissue | 2 (13.3) | 1 (6.7) | |
 Urine | 4 (26.7) | 3 (20) | |
 Other/unknown | 2 (13.3) | 3 (20) | |
APACHE II (median, IQR) | 29 (23,41) | 33 (31,41) | 0.20 |
Serum lactate at enrollment, mmol/dL (median, IQR) | 3.6 (2.3–5.0) | 3.6 (2.0–5.9) | 0.97 |
Mean arterial pressure at enrollment, mmHg (median, IQR) | 63 (54–74) | 70 (67–84) | 0.03 |
Mechanical ventilation during study period (n, %) | 2 (13) | 6 (40) | 0.22 |
NEEa at enrollment (mcg/kg/min, median, IQR) | 0.1 (0,0.29) | 0.04 (0, 0.2) | 0.45 |